Steven Magnuson

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 398 citations · Full text

A Novel Tankyrase Small-Molecule Inhibitor Suppresses <i>APC</i> Mutation–Driven Colorectal Tumor Growth

Ted Lau, Emily Chan, Marinella Callow et al. · Cancer Research · 2013 · 317 citations

Two-directional synthesis and its use in natural product synthesis

Steven Magnuson · Tetrahedron · 1995 · 209 citations

Engineering, Organic Chemistry, Two-directional Synthesis +3

Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors

F. Anthony Romero, Alexander M. Taylor, Terry D. Crawford et al. · Journal of Medicinal Chemistry · 2015 · 188 citations · Full text

Drug Target, Pharmacotherapy, Pharmaceutical Chemistry +18

Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer

Lingyan Jin, Jesse Garcia, Emily Chan et al. · Cancer Research · 2017 · 149 citations · Full text